Statistical Software for Data Analysis and Clinical Trials
Drug Products: Biologics, Biosimilars and Interchangeables
Methods of Documentation III: PIE
Trial and Error and Algorithm
Clinical Trials: Overview
Clinical Trials
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 10, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Robert E Weiss1, Xiaomao Xia2, Nan Zhang3
1Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles, 90095-1772, CA, USA.
This study introduces Bayesian methods to analyze biosimilar clinical trials, potentially reducing sample sizes. The approach uses prior information from earlier development steps and meta-analyses to improve trial power and efficiency for biosimilar drug approval.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: